TY - JOUR T1 -门诊治疗继发性自发性气胸:随机对照试验JF -欧洲呼吸杂志》乔和J - 10.1183/13993003.03375 -2020欧元SP - 2003375 AU -沃克,Steven P AU -基南艾玛盟——Bintcliffe奥利弗AU -斯坦顿,安德鲁·E AU -罗伯茨,马克盟——Pepperell贾斯汀AU -费尔贝恩,伊恩AU -部,爱德华盟一同,詹姆斯盟——MaddekarNadeem AU - Walters, James AU - West, Alex AU - Bhatta, Amrithraj AU - Knight, Matthew AU - Mercer, Rachel AU - halifax, Rob AU - White, Paul AU - Miller, Robert F AU - Rahman, Najib M AU - Maskell，继发性自发性气胸(SSP)的传统治疗方法是将肋间胸腔导管与水下密封装置相连。我们研究了单向颤振阀的使用是否缩短了患者的住院时间。方法采用开放式随机对照试验，随机选择胸管和水下密封(标准护理:SC)或使用颤振阀的门诊护理(AC)患者。使用的颤振阀的类型取决于患者是否在随机分组中已经有了胸膜管:在没有胸膜管的患者中使用了胸腔通气(PV);在那些原位有胸管的患者中，附加心房压肺器(AP)瓣膜。主要终点是LoS。在2017年3月至2020年3月期间，41例患者接受了随机分组:20例为SC, 21例为AC (13=PV, 8=AP)。 There was no difference in LoS in the first 30 days following treatment intervention: AC (median=6 days, IQR 14.5) and SC (median=6 days, IQR 13.3). In patients treated with PV there was a high rate of early treatment failure (6/13; 46%), compared to patients receiving SC (3/20; 15%) (p=0.11) Patients treated with AP had no (0/8 0%) early treatment failures and a median LoS of 1.5 days (IQR 23.8).Conclusion There was no difference in LoS between ambulatory and standard care. Pleural Vents had high rates of treatment failure and should not be used in SSP. Atrium Pneumostats are a safer alternative, with a trend towards lower LOSFootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.Conflict of interest: Dr. Walker reports grants from Rocket Medical, during the conduct of the study;.Conflict of interest: Dr. Keenan has nothing to disclose.Conflict of interest: Dr. Bintcliffe has nothing to disclose.Conflict of interest: Dr. Stanton has nothing to disclose.Conflict of interest: Dr. Roberts has nothing to disclose.Conflict of interest: Dr. pepperell has nothing to disclose.Conflict of interest: Dr. Fairbairn has nothing to disclose.Conflict of interest: Dr. McKeown has nothing to disclose.Conflict of interest: Dr. Goldring has nothing to disclose.Conflict of interest: Dr. Maddekar has nothing to disclose.Conflict of interest: Dr. Walters has nothing to disclose.Conflict of interest: Dr. West has nothing to disclose.Conflict of interest: Dr. BHATTA has nothing to disclose.Conflict of interest: Dr. Knight has nothing to disclose.Conflict of interest: Dr. Mercer has nothing to disclose.Conflict of interest: Dr. Hallifax has nothing to disclose.Conflict of interest: Dr. White has nothing to disclose.Conflict of interest: Dr. Miller reports personal fees from Gilead, outside the submitted work;.Conflict of interest: Dr. Rahman reports personal fees from Rocket Medical, outside the submitted work;.Conflict of interest: Dr. Maskell reports grants from Rocket Medical, during the conduct of the study; personal fees from BD Carefusion, personal fees from Cook Medical, outside the submitted work;. ER -